Is a complete ENLV research report available?

No complete published report is available for Enlivex Ltd. (ENLV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Enlivex Ltd. (ENLV)

NASDAQ: ENLV · USD

$2.60

-0.10 (-3.7%)· Recorded snapshot

Market cap	3.2M
Net income (ttm)	3.2B
EPS (ttm)	$4,469
Shares out	1.2M
P/E (trailing)	0.0x
Volume	34,740
Beta	1.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 3.2B
EPS (ttm): $4,469
P/E (trailing): 0.0x
Market cap: 3.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001596812
Company name	Enlivex Ltd.
Country	Israel
Country code	US
CUSIP number	M20156127
Earnings date	2026-11-13
Earnings time	amc
Employees	34
Employees change	-37
Employees growth	-52.11%
Enterprise value	$15.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2005
Industry	Biotechnology
IPO date	1995-12-12
Is primary listing	Yes
Is SPAC	No
ISIN number	IL0011319527
Last 10-K release date	2008-03-17
Last earnings date	2026-09-25
Last refreshed	2026-10-28
Last stock split date	2026-10-27
Last stock split type	Reverse
Market cap	$3.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$2.60
Price currency	USD
Sector	Healthcare
SIC code	6199
Stock price date	2026-10-28
Symbol	ENLV
Website	https://www.enlivex.com

Metric

Value

Amount currency

USD

CIK code

0001596812

Company name

Enlivex Ltd.

Country

Israel

Country code

CUSIP number

M20156127

Earnings date

2026-11-13

Earnings time

amc

Employees

Employees change

-37

Employees growth

-52.11%

Enterprise value

$15.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2005

Industry

Biotechnology

IPO date

1995-12-12

Is primary listing

Yes

Is SPAC

ISIN number

IL0011319527

Last 10-K release date

2008-03-17

Last earnings date

2026-09-25

Last refreshed

2026-10-28

Last stock split date

2026-10-27

Last stock split type

Reverse

Market cap

$3.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$2.60

Price currency

USD

Sector

Healthcare

SIC code

6199

Stock price date

2026-10-28

Symbol

ENLV

Website

https://www.enlivex.com

Metric	Value
Earnings yield	171,891.85%
EV/Earnings	0x
FCF / EV yield	-101.18%
FCF yield	-463.36%
Graham number	19303.30734
Graham upside	714,837.31%
P/B ratio	0x
P/E ratio	0x
Price / tangible book value	0x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

171,891.85%

EV/Earnings

FCF / EV yield

-101.18%

FCF yield

-463.36%

Graham number

19303.30734

Graham upside

714,837.31%

P/B ratio

P/E ratio

Price / tangible book value

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Effective tax rate	23.32%
Profit per employee	$93.8M
Profitable quarters	2
Profitable years	1
ROA	-0.61%
ROA (5Y)	-19.48%
ROCE	-0.5%
ROE	162.86%
ROE (5Y)	-12.89%
ROIC	-0.64%
ROIC (5Y)	-361.79%

Metric

Value

Effective tax rate

23.32%

Profit per employee

$93.8M

Profitable quarters

Profitable years

ROA

-0.61%

ROA (5Y)

-19.48%

ROCE

-0.5%

ROE

162.86%

ROE (5Y)

-12.89%

ROIC

-0.64%

ROIC (5Y)

-361.79%

Metric	Value
EPS growth (QoQ)	80.28%
EPS growth quarters	9
EPS growth years	3
Net income growth (QoQ)	94.11%
Net income growth quarters	9
Net income growth years	3
Revenue growth years	0

Metric

Value

EPS growth (QoQ)

80.28%

EPS growth quarters

EPS growth years

Net income growth (QoQ)

94.11%

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-38,000
Depreciation and amortization	$278,000
EBIT	$-24.2M
EBITDA	$-23.9M
EPS	$4,469.19
FCF per share	$-12.51
Financing cash flow	$33.3M
Free cash flow	$-15.6M
Free cash flow minus SBC	$-23.5M
Income taxes	$969.9M
Investing cash flow	$-14.1M
Net borrowing	$17.9M
Net cash flow	$3.7M
Net income	$3.2B
Operating cash flow minus SBC	$-23.5M
Operating income	$-24.2M
Stock-based compensation	$7.9M

Metric

Value

Capital expenditures

$-38,000

Depreciation and amortization

$278,000

EBIT

$-24.2M

EBITDA

$-23.9M

EPS

$4,469.19

FCF per share

$-12.51

Financing cash flow

$33.3M

Free cash flow

$-15.6M

Free cash flow minus SBC

$-23.5M

Income taxes

$969.9M

Investing cash flow

$-14.1M

Net borrowing

$17.9M

Net cash flow

$3.7M

Net income

$3.2B

Operating cash flow minus SBC

$-23.5M

Operating income

$-24.2M

Stock-based compensation

$7.9M

Metric	Value
Book value per share	$3,705.55
Debt / equity	0
Long-term assets	$1.1B
Long-term liabilities	$970.3M
Net cash (debt)	$-12M
Net cash / market cap	-357.96%
Net debt / equity	0
Piotroski F-Score	2
Property, plant and equipment	$838,000
Shareholders' equity	$3.9B
Tangible book value	$3.9B
Tangible book value per share	$3,705.55
Total assets	$4.9B
Total cash	$5.5M
Total debt	$17.5M
Total liabilities	$1B
WACC	1.93%

Metric

Value

Book value per share

$3,705.55

Debt / equity

Long-term assets

$1.1B

Long-term liabilities

$970.3M

Net cash (debt)

$-12M

Net cash / market cap

-357.96%

Net debt / equity

Piotroski F-Score

Property, plant and equipment

$838,000

Shareholders' equity

$3.9B

Tangible book value

$3.9B

Tangible book value per share

$3,705.55

Total assets

$4.9B

Total cash

$5.5M

Total debt

$17.5M

Total liabilities

$1B

WACC

1.93%

Metric	Value
Current assets	$3.8B
Current liabilities	$31.4M
Current ratio	119.39
Net working capital	$3.7B
Quick ratio	0.19
Working capital	$3.7B

Metric

Value

Current assets

$3.8B

Current liabilities

$31.4M

Current ratio

119.39

Net working capital

$3.7B

Quick ratio

0.19

Working capital

$3.7B

Metric	Value
Buyback yield / dilution	-649.71%
Dividend yield	0%
Shareholder yield	-649.71%

Metric

Value

Buyback yield / dilution

-649.71%

Dividend yield

Shareholder yield

-649.71%

Metric	Value
150-day SMA	$101.44
1D price change	-3.7%
1M price change	-72.73%
1M total return	-72.73%
1W price change	-27.16%
1W total return	-27.16%
1Y price change	-98.99%
1Y return CAGR	-99%
1Y total return	-98.99%
20-day SMA	$3.98
200-day SMA	$141.52
3M price change	-96.18%
3M total return	-96.18%
3Y price change	-99.18%
3Y return CAGR	-79.85%
3Y total return	-99.18%
50-day SMA	$11.51
50-day SMA vs 200-day SMA	50under200
52-week high	$434.40
52-week high date	2025-11-24
52-week low	$2.22
52-week low date	2026-10-27
5Y price change	-99.87%
5Y return CAGR	-73.44%
5Y total return	-99.87%
6M price change	-98.77%
6M total return	-98.77%
All-time high	$10,776.00
All-time high date	2019-09-23
All-time low	$2.22
All-time low date	2026-10-27
Average true range (ATR)	$0.98
Average volume	156.4K
Beta (1Y)	0.72
Beta (2Y)	0.53
Beta (5Y)	1.41
Change from 52-week high	-99.4%
Change from 52-week low	17.38%
Change from all-time high	-99.98%
Change from all-time low	17.7%
Change from open	-1.52%
Day's gap	-2.22%
Dollar volume	$90,324
High price	$2.64
Low price	$2.59
Monthly RSI	31.78
Open price	$2.64
Position in 52-week range	20%
Premarket change	0.74%
Premarket close	$2.70
Premarket price	$2.72
Premarket volume	7.7K
Previous close	$2.70
Price vs 150-day SMA	-97.43%
Price vs 20-day SMA	-34.43%
Price vs 200-day SMA	-98.16%
Price vs 50-day SMA	-77.35%
Relative volume	0.22
RSI	14.36
Sharpe ratio	-4.13
Sharpe ratio (3Y)	-1.14
Sharpe ratio (5Y)	-1.12
Sortino ratio	-4.58
Sortino ratio (3Y)	-1.46
Sortino ratio (5Y)	-1.44
Volume	34.7K
Weekly RSI	19.44
YTD price change	-98.46%
YTD total return	-98.46%

Metric

Value

150-day SMA

$101.44

1D price change

-3.7%

1M price change

-72.73%

1M total return

-72.73%

1W price change

-27.16%

1W total return

-27.16%

1Y price change

-98.99%

1Y return CAGR

-99%

1Y total return

-98.99%

20-day SMA

$3.98

200-day SMA

$141.52

3M price change

-96.18%

3M total return

-96.18%

3Y price change

-99.18%

3Y return CAGR

-79.85%

3Y total return

-99.18%

50-day SMA

$11.51

50-day SMA vs 200-day SMA

50under200

52-week high

$434.40

52-week high date

2025-11-24

52-week low

$2.22

52-week low date

2026-10-27

5Y price change

-99.87%

5Y return CAGR

-73.44%

5Y total return

-99.87%

6M price change

-98.77%

6M total return

-98.77%

All-time high

$10,776.00

All-time high date

2019-09-23

All-time low

$2.22

All-time low date

2026-10-27

Average true range (ATR)

$0.98

Average volume

156.4K

Beta (1Y)

0.72

Beta (2Y)

0.53

Beta (5Y)

1.41

Change from 52-week high

-99.4%

Change from 52-week low

17.38%

Change from all-time high

-99.98%

Change from all-time low

17.7%

Change from open

-1.52%

Day's gap

-2.22%

Dollar volume

$90,324

High price

$2.64

Low price

$2.59

Monthly RSI

31.78

Open price

$2.64

Position in 52-week range

20%

Premarket change

0.74%

Premarket close

$2.70

Premarket price

$2.72

Premarket volume

7.7K

Previous close

$2.70

Price vs 150-day SMA

-97.43%

Price vs 20-day SMA

-34.43%

Price vs 200-day SMA

-98.16%

Price vs 50-day SMA

-77.35%

Relative volume

0.22

RSI

14.36

Sharpe ratio

-4.13

Sharpe ratio (3Y)

-1.14

Sharpe ratio (5Y)

-1.12

Sortino ratio

-4.58

Sortino ratio (3Y)

-1.46

Sortino ratio (5Y)

-1.44

Volume

34.7K

Weekly RSI

19.44

YTD price change

-98.46%

YTD total return

-98.46%

Metric	Value
Float	485.3K
Float percentage	39%
Shares change (QoQ)	7.64%
Shares change (YoY)	649.71%
Shares held by insiders	2.45%
Shares held by institutions	9.36%
Shares outstanding	1.2M
Short % of shares	0.5%
Short ratio	0.2 days

Metric

Value

Float

485.3K

Float percentage

39%

Shares change (QoQ)

7.64%

Shares change (YoY)

649.71%

Shares held by insiders

2.45%

Shares held by institutions

9.36%

Shares outstanding

1.2M

Short % of shares

0.5%

Short ratio

0.2 days

Enlivex Ltd. (ENLV)

Price

Financial snapshot

Fair-value bridge

Latest news · ENLV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENLV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ENLV

Frequently asked questions